Dendreon Corp fka DNDNQ

[nerdseeksblonde]

science doesn't sell itself,
one job of management is to make the produce
value and make it obvious. If you really
mean politics you mean fraud. There may be
some shrewdness in competitive tactics but
when push comes to shove the value is largely
in the science. This is true of any business,
except here it is what people are used to thinking
of as science.
Making product attributes known, selling and
honestly promoting it, isn't politics as much
as marketing. If the product is that
good, even in some niche, the CEO has to discover and push this
information, not political maneuering[sic]. This
works on the FDA, the prescribers, patient advocates,
and maybe even Mr. Garcia would be interested and
you don't have to worry about it exploding.
There is always risk that some information isn't too
flattering but you need to find more information and
context until you get the best answer, not try to spin it
and hope no one notices.

Given all the interest in immunotherapy and the questionable clinical data, it is a bit disconcerting the only outside collaborator they have found in these last few years couldn't even get his plane to DC. You;d think people would be beating down the doors for cost-share collaborations with this
first working immunotherapy. If they really had confidence in it, or could even use some shrewd tactics to get
sceptical researchers to "try it," everyone with applicable
research funding would be playing around with provenge
variants.

Talk to AFFX or any other array company,
you'd think they could find a cost effective way
to characterize provenge maturation just by brute force-
look at mRNA in the culture medium as a function of
time and look for obvious things that correlate with
improved survival etc.